The country’s top drugmakers are set to meet in early December at the Four Seasons hotel in Georgetown with Donald Trump Jr.

Good morning. We are officially one week out from the STAT Summit. I’m excited to see my colleagues IRL, to eat great snacks, ...

From my colleague Allison DeAngelis: Private equity billionaire Tony James is backing a new life sciences investment firm ...

In a setback for Sarepta Therapeutics, a New York panel has voted unanimously to recommend the state Medicaid program pause ...

A federal appeals court unanimously rejected a Novo Nordisk challenge to Medicare’s drug price negotiation program, a ruling ...

Story Health is the fourth Innovaccer acquisition in about a year as it aims to become the default AI platform for health ...

Informed consent is integral to providing high-quality health care, yet it is too often treated as an obstacle — just a box ...

Pharma companies are hoping to announce deals of their own with President Trump as soon as this week, sources told STAT.

At the Supreme Court, a majority of justices seemed poised to rule against a Colorado law banning so-called conversion ...

As a career clinical trialist, I immediately wondered: What if this tool were used for trial visits? Could it enable a ...

Peter Marks, the former top vaccine regulator at the FDA, has joined Eli Lilly — a move likely to rile up critics of the ...

When I think of patients who refuse treatment, I don't automatically assume they're uninformed. I kind of assume that they're just informed by different facts.” ...